Localization of insulin-like growth factor-II mRNA in human pituitary adenomas

Virchows Archiv

Volumn 432, Issue 3, 1998, Pages 241-246

  Yokoyama, Shunichi ^a   Thapar, Kamal ^a   Kovacs, Kalman ^a   Stefaneanu, Lucia ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Cell proliferation; Human pituitary; Insulin like growth factor II; Neoplasm; Pathology

Indexed keywords

GROWTH HORMONE; MESSENGER RNA; PROLACTIN; SOMATOMEDIN B;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IN SITU HYBRIDIZATION; LABELING INDEX; MALE; PRIORITY JOURNAL; PROLACTIN SECRETING CELL; PROTEIN EXPRESSION; STEM CELL;

ADENOMA; ADENOMA, ACIDOPHIL; FEMALE; HUMANS; IN SITU HYBRIDIZATION; INSULIN-LIKE GROWTH FACTOR II; KI-67 ANTIGEN; MALE; PITUITARY NEOPLASMS; PROLACTINOMA; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0031940960     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050161     Document Type: Article

References (41)

1. Bach MA, Bondy CA (1992) Anatomy of the pituitary insulin-like growth factor system. Endocrinology 131:2588-2594
2. Baker J, Liu JP, Robertson EJ, Efstratiadis A (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82
3. Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B (1997) The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1332:F105-F126
4. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol (Lond) 168:357-363
5. Ceda GP, Hoffman AR, Silverberg GD, Wilson DM, Rosenfeld RG (1985) Regulation of growth hormone release from cultured human adenomas by somatomedius and insulin. J Clin Endocrinol Metab 60:1204-1209
6. Ceda GP, Davis RG, Rosenfeld RG, Hoffman AR (1987) The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II. Endocrinology 120:1658-1662
7. Christofori G, Naik P, Hanahan D (1994) A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369:414-418
8. DeChiara TM, Efstratiadis A, Robertson EJ (1990) A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345:78-80
9. DeChiara TM, Robertson EJ, Efstratiadis A (1991) Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64:849-859
10. Gelato MC, Vassalotti J, Spatola E, Rutherford C, Marsh K, Carlson HE (1992) Differential tissue regulation of the insulin-like growth factors in rats bearing the MStT/W15 pituitary tumor. Neuroendocrinology 56:765-774
11. Giudice LC, Zegher F de, Gargosky SE, Dsupin BA, Las Fuentes de L, Crystal RA, Hintz RL, Rosenfeld RG (1995) Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 80:1548-1555
12. Glick RP, Unterman TG (1995) Radioimmunoassay of insulin-like growth factors I and II in the cerebrospinal fluid of patients with pituitary and other central nervous system tumors. Neurosurgery 36:556-563
13. Goodyer CG, De SL, Lai WH, Guyda HJ, Posner BI (1984) Characterization of insulin-like growth factor receptors in rat anterior pituitary, hypothalamus, and brain. Endocrinology 114:1187-1195
14. Goodyer CG, Marcovitz S, Hardy J, Lefebvre Y, Guyda HJ, Posner BI (1986) Effect of insulin-like growth factors on human foetal, adult normal and tumour pituitary function in tissue culture. Acta Endocrinol (Copenh) 112:49-57
15. Harris PE, Daniels M, James RA, Turner SJ, Dewar J, Kendall-Taylor P (1991) Effects of insulin-like growth factor-II on growth hormone release from human somatotrophinoma cells in vitro. J Endocrinol 129:447-451
16. Haselbacher GK, Schwab ME, Pasi A, Humbel RE (1985) Insulin-like growth factor II (IGF II) in human brain: regional distribution of IGF II and of higher molecular mass forms. Proc Natl Acad Sci USA 82:2153-2157
17. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580
18. Kim JD, Nanto-Salonen K, Szczepankiewicz JR, Rosenfeld RG, Glasscock GF (1993) Evidence for pituitary regulation of somatic growth, insulin-like growth factors-I and -II, and their binding proteins in the fetal rat. Pediatr Res 33:144-151
19. Knops E, Kitz K, Perneczky A (1989) Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. Neurosurgery 25:927-930
20. Kovacs K, Horvath E (1986) Tumors of the pituitary gland. Hartmann WH (ed) Armed Forces Institute of Pathology, Washington DC, pp 1-269
21. Landolt AM, Shibata T, Kleihues P (1987) Growth rate of human pituitary adenomas. J Neurosurg 67:803-806
22. LeRoith D, Werner H, Beitner-Johnson D, Roberts CTJ (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143-163
23. Li J, Stefaneanu L, Kovacs K, Horvath E, Smyth HS (1993) Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas. Virchows Arch [A] 422:193-201
24. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type I IGF receptor (Igf1r). Cell 75:59-72
25. Lü F, Yang K, Han VKM, Challis JRG (1995) Expression, distribution, regulation and function of IGFs in the ovine fetal pituitary. J Mol Endocrinol 14:323-336
26. Pelosi G, Zamboni G (1996) Proliferation markers and their uses in the study of endocrine tumors. Endocr Pathol 7:103-119
27. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA (1993) IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609-2617
28. Rogler CE, Yang D, Rossetti L, Donohoe J, Alt F, Chang CJ, Neely K, Hintz R (1994) Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem 269:13779-13784
29. Rosenfeld RG, Ceda G, Cutler CW, Dollar LA, Hoffman AR (1985) Insulin and insulin-like growth factor (somatomedin) receptors on cloned rat pituitary tumor cells. Endocrinology 117:2008-2016
30. Rubin R, Baserga R (1995) Biology of disease. Insulin-like growth factor-1 receptor. Its role in cell proliferation, apoptosis and tumorigenicity. Lab Invest 73:311-330
31. Shibuya M, Saito F, Miwa T, Davis RL, Wilson CB, Hoshino T (1992) Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts. Acta Neuropathol (Berl) 84:178-183
32. Simes JM, Wallace JC, Walton PE (1991) The effects of insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-1, a potent IGF analogue, on growth hormone and IGF-binding protein secretion from cultured rat anterior pituitary cells. J Endocrinol 130:93-99
33. Soldani R, Cagnacci A, Yen SS (1994) Insulin, insulin-like growth factor I (IGF-I) and IGF-II enhance nasal and gonadotrophin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro. Eur J Endocrinol 131:641-645
34. Stefaneanu L, Rindi G, Horvath E, Murphy D, Polak JM, Kovacs K (1992) Morphology of adenohypophysial tumors in mice transgenic for vasopressin-SV40 hybrid oncogene. Endocrinology 130:1789-1795
35. Stefaneanu L, Thapar K, Kovacs K (1995) In situ hybridization study of insulin-like growth factor-I in human pituitary adenomas. J Surg Pathol 2 [suppl]: abstr 182
36. Taylor CR, Shi SR, Chaiwun B, Young E, Imam SA, Cote RJ (1994) Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques. Hum Pathol 25:263-270
37. Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, Murray D, Laws ERJ (1996) Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38:99-106
38. Turner JD, Rotwein P, Novakofski J, Bechtel PJ (1988) Induction of mRNA for IGF-I and -II during growth hormone-stimulated muscle hypertrophy. Am J Physiol 255:E513-E517
39. Weber MM, Melmed S, Rosenbloom J, Yamasaki H, Prager D (1992) Rat somatotroph insulin-like growth factor-II (IGF-II) signaling: role of the IGF-I receptor. Endocrinology 131: 2147-2153
40. Westley BR, May FEB (1994) Role of insulin-like growth factors in steroid modulated proliferation. J Steroid Biochem Molec Biol 51:1-9
41. Zarrilli R, Pignata S, Romano M, Gravina A, Casola S, Bruni CB, Acquaviva AM (1994) Expression of insulin-like growth factor (IGF)-II and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells. Cell Growth Differ 5:1085-1091